DK371886D0 - CEPHALOSPORIN SALTS AND INJECTABLE PREPARATIONS - Google Patents

CEPHALOSPORIN SALTS AND INJECTABLE PREPARATIONS

Info

Publication number
DK371886D0
DK371886D0 DK371886A DK371886A DK371886D0 DK 371886 D0 DK371886 D0 DK 371886D0 DK 371886 A DK371886 A DK 371886A DK 371886 A DK371886 A DK 371886A DK 371886 D0 DK371886 D0 DK 371886D0
Authority
DK
Denmark
Prior art keywords
injectable preparations
cephalosporin salts
cephalosporin
salts
injectable
Prior art date
Application number
DK371886A
Other languages
Danish (da)
Other versions
DK162053C (en
DK162053B (en
DK371886A (en
Inventor
Murray A Kaplan
Thomas W Hudyma
Robert A Lipper
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK371886D0 publication Critical patent/DK371886D0/en
Publication of DK371886A publication Critical patent/DK371886A/en
Publication of DK162053B publication Critical patent/DK162053B/en
Application granted granted Critical
Publication of DK162053C publication Critical patent/DK162053C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
DK371886A 1985-08-05 1986-08-04 TEMPERATURE-STABLE CRYSTALLINIC SALTS OF 7-OEALFA- (2-AMINO-THIAZOL-4-YL) -ALFA- (Z) -METHOXYIMINOACETAMIDOAA-3-OE (1-ETHYL-1-PYRROLIDINIUM) -METHYLAA-3-METHYLAA-3-CE , PHYSICAL MIXTURES OF THE SALTS AND PROCEDURES FOR THE PREPARATION OF THE SULFURIC ACID ADDITION SALT DK162053C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05
US76223585 1985-08-05

Publications (4)

Publication Number Publication Date
DK371886D0 true DK371886D0 (en) 1986-08-04
DK371886A DK371886A (en) 1987-02-06
DK162053B DK162053B (en) 1991-09-09
DK162053C DK162053C (en) 1992-02-10

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
DK371886A DK162053C (en) 1985-08-05 1986-08-04 TEMPERATURE-STABLE CRYSTALLINIC SALTS OF 7-OEALFA- (2-AMINO-THIAZOL-4-YL) -ALFA- (Z) -METHOXYIMINOACETAMIDOAA-3-OE (1-ETHYL-1-PYRROLIDINIUM) -METHYLAA-3-METHYLAA-3-CE , PHYSICAL MIXTURES OF THE SALTS AND PROCEDURES FOR THE PREPARATION OF THE SULFURIC ACID ADDITION SALT

Country Status (34)

Country Link
JP (1) JPH0615548B2 (en)
KR (1) KR930003121B1 (en)
AR (1) AR243894A1 (en)
AT (1) AT390957B (en)
AU (1) AU597262B2 (en)
BE (1) BE905219A (en)
CA (1) CA1284994C (en)
CH (1) CH675581A5 (en)
CS (2) CS276717B6 (en)
CY (1) CY1614A (en)
DD (2) DD254941A5 (en)
DE (1) DE3626375A1 (en)
DK (1) DK162053C (en)
EG (1) EG18003A (en)
ES (1) ES2002112A6 (en)
FI (1) FI84484C (en)
FR (1) FR2585705B1 (en)
GB (1) GB2179936B (en)
GR (1) GR862055B (en)
HK (1) HK99691A (en)
HU (1) HU196602B (en)
IE (1) IE59222B1 (en)
IL (1) IL79608A (en)
IT (1) IT1197067B (en)
LU (2) LU86540A1 (en)
MY (1) MY102212A (en)
NL (1) NL8601991A (en)
OA (1) OA08672A (en)
PT (1) PT83134B (en)
SE (1) SE469633B (en)
SG (1) SG79791G (en)
SU (1) SU1516013A3 (en)
YU (1) YU45793B (en)
ZA (1) ZA865842B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
WO1988010263A1 (en) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
JPH02101081A (en) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd Crystalline dihydrochloride of cephalosporin derivative and production thereof
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
JP4616844B2 (en) 2003-12-23 2011-01-19 サンド・ゲーエムベーハー Production process of intermediates for use in the synthesis of cephalosporin
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (en) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmaceutical preparation containing an antiviral dihydroquinazoline derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (en) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING CEPHALOSPORINES
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
OA08672A (en) 1989-03-31
CA1284994C (en) 1991-06-18
MY102212A (en) 1992-05-15
JPS62103090A (en) 1987-05-13
PT83134A (en) 1986-09-01
IE59222B1 (en) 1994-01-26
DK162053C (en) 1992-02-10
SG79791G (en) 1991-11-15
SE8603308D0 (en) 1986-08-04
IT1197067B (en) 1988-11-25
IT8621409A1 (en) 1988-02-04
LU88574I2 (en) 1995-03-01
IL79608A (en) 1991-07-18
FI84484B (en) 1991-08-30
JPH0615548B2 (en) 1994-03-02
KR880002530A (en) 1988-05-09
AT390957B (en) 1990-07-25
LU86540A1 (en) 1987-03-06
AU597262B2 (en) 1990-05-31
FI863155A0 (en) 1986-08-01
KR930003121B1 (en) 1993-04-19
SE8603308L (en) 1987-02-06
DK162053B (en) 1991-09-09
SU1516013A3 (en) 1989-10-15
GB2179936B (en) 1989-04-26
YU45793B (en) 1992-07-20
FI863155A (en) 1987-02-06
CY1614A (en) 1992-07-10
PT83134B (en) 1989-07-31
SE469633B (en) 1993-08-09
GB8618989D0 (en) 1986-09-17
HK99691A (en) 1991-12-13
DD268395A5 (en) 1989-05-31
AR243894A1 (en) 1993-09-30
AU6069486A (en) 1987-02-12
NL8601991A (en) 1987-03-02
CS276849B6 (en) 1992-08-12
ES2002112A6 (en) 1988-07-16
CH675581A5 (en) 1990-10-15
DD254941A5 (en) 1988-03-16
HUT41802A (en) 1987-05-28
FR2585705A1 (en) 1987-02-06
GB2179936A (en) 1987-03-18
EG18003A (en) 1991-08-30
DK371886A (en) 1987-02-06
YU137186A (en) 1987-12-31
FI84484C (en) 1991-12-10
GR862055B (en) 1986-12-24
BE905219A (en) 1987-02-04
IL79608A0 (en) 1986-11-30
IE862078L (en) 1987-02-05
ATA211086A (en) 1990-01-15
DE3626375A1 (en) 1987-02-12
FR2585705B1 (en) 1989-01-13
CS276717B6 (en) 1992-08-12
HU196602B (en) 1988-12-28
ZA865842B (en) 1987-04-29
IT8621409A0 (en) 1986-08-04

Similar Documents

Publication Publication Date Title
DK151686D0 (en) hydroxamates
DK289886D0 (en) SUBSTITUTED 3-PHENYL-4-CYANOPYRROL DERIVATIVES AND THEIR PREPARATION AND USE
DK359686D0 (en) LYOFILIZED EMULSING AGENTS AND PROCEDURE
FR2590799B1 (en) SYRINGE
DK371886A (en) CEPHALOSPORIN SALTS AND INJECTABLE PREPARATIONS
DK29686A (en) 13BETA-ALKYL-MILBEMYCINE DERIVATIVES AND THEIR PREPARATION AND USE
DK133786D0 (en) PREPARATIONS
DK139286A (en) INSIDE AND NAPHTHALENDER DERIVATIVES
DK470886D0 (en) OXAZOLE AND ISOXAZOLD DERIVATIVES
DK24986D0 (en) PREPARATIONS
IT1229176B (en) ANTIBIOTICS ANTI-TUMORAL BBM-1675C AND D
DK172486D0 (en) HETEROCYCLYL-PENEM COMPOUNDS AND THEIR PREPARATION AND USE
DE3662889D1 (en) TETRAHYDROFURANCARBOXYLIC-ACID DERIVATIVES
FR2588259B1 (en) BIS-ACRIDINIQUES SINGLE-BRIDGE AND BIS-ACRIDINIQUES BIPONTES
DK466086D0 (en) EXOGENTIC ACIDED ANTACIDIUM PREPARATIONS
DK77286D0 (en) 1-0-ACYLED HEXOSIDE DERIVATIVES AND THEIR PREPARATION AND USE
DK206686A (en) ACYLAMINOMETHYL-PENEM COMPOUNDS AND THEIR PREPARATION AND USE
DK553285A (en) PHENOXYPROPANOLAMINE SALTS AND PHARMACEUTICAL PREPARATIONS THEREOF
DK363786A (en) HYDROQUINOLINES AND USE THEREOF
DE3666818D1 (en) ANISOLE DERIVATIVES
DK577286D0 (en) cephalosporin
DE3662890D1 (en) FUROBENZISOXAZOLE DERIVATIVES
IT8512566A0 (en) FURNITURE JOINT
RO93833A2 (en) ANTIACNEIC AND ANTISEBOREIC SOLUTION
DK597885A (en) SACCHAROSE-FREE PREPARATIONS

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1995 00020, 951120

CTFG Supplementary protection certificate (spc) issued

Free format text: CA 1995 00020, 951120, EXPIRES: 20080629

PUP Patent expired